首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI) | P&T Community

【24h】

Tenecteplase: Innovative Fibrinolysis for ST-Segment Elevation Myocardial Infarction (STEMI) | P&T Community

机译：替奈普酶：ST段抬高型心肌梗死（STEMI）的创新纤维蛋白溶解P＆T社区

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《P & T: a peer-reviewed journal for formulary management》 |2003年第1期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Improved speed and stability of ST-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute ST-segment elevation myocardial infarction. [J] . Roe MT, Green CL, Giugliano RP, Journal of the American College of Cardiology . 2004,第4期

机译：与全剂量替奈普酶相比，减少剂量的替奈普酶和依替巴肽可改善急性ST段抬高型心肌梗塞的ST段恢复的速度和稳定性。
2. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the Strategic Reperfusion Early After Myocardial infarction trial (vol 169, pg 890, 2015) [J] . Armstrong Paul W., Zheng Yinggan, Westerhout Cynthia M., The American heart journal . 2017,第期

机译：减少了Dose Tenecteplase和老年人ST段抬高的结果，心肌梗死患者：心肌梗死试验早期战略再灌注的见解（Vol 169，PG 890,2015）
3. Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial [J] . Armstrong Paul W., Zheng Yinggan, Westerhout Cynthia M., The American heart journal . 2015,第6期

机译：老年ST段抬高型心肌梗死患者的替奈普酶降低剂量和预后：心肌梗死试验后早期策略性再灌注的见解
4. The Discovery of Prognosis Factors Using Association Rule Mining in Acute Myocardial Infarction with ST-Segment Elevation [C] . Kwang Sun Ryu, Hyun Woo Park, Soo Ho Park, International conference on information technology in bio- and medical informatics . 2015

机译：关联规则挖掘在急性ST段抬高心肌梗死中的预后因素发现
5. The prognosis and outcomes of patients with a ST-segment elevation myocardial infarction and the biochemical and clinical inflammatory response [D] . van Diepen, Sean frederick 2013

机译：ST段升高心肌梗死患者的预后和结果及生物化学和临床炎症反应
6. Improved Survival of Patients with ST-Segment Elevation Myocardial Infarction 3–6 Hours After Symptom Onset Is Associated with Inter-Hospital Transfer for Primary Percutaneous Coronary Intervention (PCI) at a Large Regional ST-Segment Elevation Myocardial Infarction (STEMI) Program vs. In-Hospital Thrombolysis in a Community Hospital [O] . Xiangmei Zhao, Xianzhi Yang, Chuanyu Gao, 2017

机译：在大型区域性ST段抬高型心肌梗死（STEMI）计划中在较大的区域性ST段抬高型心肌梗死（STEMI）计划下症状发作与症状发作与住院间转移相关的原发性经皮冠状动脉介入治疗（PCI）的ST段抬高型心肌梗死患者的生存改善。 -社区医院的溶栓治疗
7. Improved speed and stability of st-segment recovery with reduced-dose tenecteplase and eptifibatide compared with full-dose tenecteplase for acute st-segment elevation myocardial infarction [O] . Roe Matthew T, Green Cynthia L, Giugliano Robert P, 2004

机译：与全剂量替奈普酶相比，减少剂量的替奈普酶和依替巴肽治疗急性st-segment升高的心肌梗死的st段恢复的速度和稳定性提高

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号